| Date Filed | Type | Description |
| 02/04/2005 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/05/2005 |
SC 13G/A
| KOPP INVESTMENT ADVISORS LLC reports a 3.1% stake in Endocardial Solutions Inc. |
| 12/20/2004 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition: |
| 11/09/2004 |
8-K
| Quarterly results |
| 11/09/2004 |
10-Q
| Quarterly Report for the period ended September 30, 2004 |
| 10/22/2004 |
8-K
| Quarterly results, Resignation/termination of a director |
| 10/18/2004 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
| 09/30/2004 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
| 09/28/2004 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| 09/28/2004 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits|
Docs:
|
"Agreement and Plan of Merger, by and among the Company, St. Jude Medical, Inc. and Dragonfly Merger Corp",
"Amendment No. 1 to Rights Agreement, between the Company and Wells Fargo Bank, N.A",
"Limited Waiver and Amendment to Loan Documents, by and between the Company and Silicon Valley Bank",
"St. Jude Medical and Endocardial Solutions, Inc. Jointly Announce Agreement Whereby St. Jude Medical Will Acquire Endocardial Solutions" |
|
| 09/13/2004 |
8-K
| Entry into a Material Definitive Agreement |
| 08/09/2004 |
10-Q
| Quarterly Report for the period ended June 30, 2004 |
| 08/06/2004 |
10-Q/A
| Quarterly Report for the period ended March 31, 2004 [amend] |
| 07/22/2004 |
8-K
| Quarterly results |
| 05/07/2004 |
10-Q
| Quarterly Report for the period ended March 31, 2004 |
| 04/22/2004 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements |
| 04/22/2004 |
8-K
| Quarterly results |
| 04/08/2004 |
SC 13G/A
| Heartland Advisors reports a 4.8% stake in ENDOCARDIAL SOLUTIONS, INC. |
| 03/15/2004 |
10-K
| Annual Report for the period ended December 31, 2003 |
| 02/17/2004 |
SC 13D/A
| MEDTRONIC INC reports a 0% stake in Endocardial Solutions, Inc. |
| 02/12/2004 |
SC 13G
| Heartland Advisors reports a 8.1% stake in ENDOCARDIAL SOLUTIONS, INC. |
| 02/06/2004 |
SC 13G
| H&Q HEALTHCARE INVESTORS reports a 5.8% stake in Endocardial Solutions |
| 01/27/2004 |
8-K
| Results of Operations and Financial Condition, Financial statements and exhibits |
| 01/26/2004 |
SC 13G/A
| KOPP INVESTMENT ADVISORS LLC reports a 14.4% stake in Endocardial Solutions Inc. |
| 11/14/2003 |
10-Q
| Quarterly Report for the period ended September 30, 2003 |
| 10/24/2003 |
8-K
| Results of Operations and Financial Condition, Financial statements and exhibits |
| 10/08/2003 |
8-K
| Other events, Financial statements and exhibits |
| 09/17/2003 |
424B3
| Form 424B3 -- Prospectus [Rule 424(b)(3)] |
| 09/02/2003 |
8-K/A
| Other events, Financial statements and exhibits |
| 08/29/2003 |
REGDEX
| Form REGDEX -- Notice of Sale of Securities [Regulation D and Section 4(6) of the Securities Act of 1933] Effectiveness Date: 2003-08-28 |
| 08/27/2003 |
8-K/A
| Other events, Financial statements and exhibits |
| 08/26/2003 |
8-K
| Other events, Financial statements and exhibits |
| 08/14/2003 |
10-Q
| Quarterly Report for the period ended June 30, 2003 |
| 07/24/2003 |
8-K
| Financial statements and exhibits, Regulation FD Disclosure |
|